Zimmer Biomet Stock Target Price and Analyst Consensus
| ZBH Stock | USD 109.97 2.40 2.23% |
The current analyst and expert consensus on Zimmer Biomet is Buy with 17 hold recommendations. The current projected Zimmer Biomet target price consensus is 124.50 with 30 analyst opinions. One of the most common ways Zimmer Biomet Holdings analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Zimmer Biomet vendors, executives, and/or customers. Zimmer Biomet recommendation module provides expert sentiment on the projected Zimmer Biomet Holdings target price to derive its highest and lowest estimates based on target price standard deviation of 1.5347.
Lowest Forecast 113.3 | Highest Forecast 138.2 | Target Price 124.5 |
Zimmer |
It's important to approach Zimmer Biomet's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Zimmer Biomet Target Price Consensus
Zimmer target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Zimmer Biomet's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 30 | Buy |
Most Zimmer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Zimmer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Zimmer Biomet Holdings, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationZimmer Biomet Target Price Projection
Zimmer Biomet's current and average target prices are 109.97 and 124.50, respectively. The current price of Zimmer Biomet is the price at which Zimmer Biomet Holdings is currently trading. On the other hand, Zimmer Biomet's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Zimmer Biomet Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Zimmer Biomet Target Price
Zimmer Biomet Analyst Ratings
Zimmer Biomet's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Zimmer Biomet stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Zimmer Biomet's financials, market performance, and future outlook by experienced professionals. Zimmer Biomet's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Zimmer Biomet price targets
Zimmer Biomet's stock target price is an estimate of its future price, usually made by analysts. Using Zimmer Biomet's target price to determine if it is a suitable investment can be done through the following steps:- Look at Zimmer Biomet's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Zimmer Biomet's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Zimmer Biomet Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Zimmer Biomet is a key component of Zimmer Biomet valuation and have some predictive power on the future returns of a Zimmer Biomet.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested few shares | |
 | ESG Investing Invested few shares | |
 | Business Services Invested few shares | |
 | Social Domain Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Zimmer Biomet to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.